Summary & Overview
CPT 64450: Peripheral Nerve Injection for Pain Management
CPT code 64450 is a widely utilized billing code for the injection of anesthetic agents and/or steroids into peripheral nerves or their branches. This procedure is essential in the management of pain and neurological conditions, offering both diagnostic and therapeutic benefits. Nationally, the code is recognized by major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, reflecting its broad clinical relevance and coverage.
This publication provides a comprehensive overview of CPT 64450, detailing its clinical applications, typical site of service, and payer coverage. Readers will gain insights into current benchmarks, policy updates, and the clinical context surrounding peripheral nerve injections. The analysis also highlights common modifiers and associated provider taxonomies, as well as relevant ICD-10 diagnoses and related CPT codes. By understanding the nuances of CPT 64450, stakeholders can better navigate the evolving landscape of pain management and procedural billing in outpatient settings.
CPT Code Overview
CPT 64450 represents the injection of anesthetic agent(s) and/or steroid into a peripheral nerve or branch, such as the trigeminal, occipital, or cervical dorsal ramus. This procedure is commonly performed for both diagnostic and therapeutic purposes on somatic nerves, often to manage pain or inflammation. The typical site of service for this procedure is the office setting (POS 11), where clinicians can efficiently deliver nerve blocks to address a range of neurological and pain-related conditions.
Clinical & Coding Specifications
Clinical Context
A patient presents to the office with persistent facial pain following a shingles outbreak, diagnosed as postherpetic trigeminal neuralgia. The provider, specializing in pain medicine or anesthesiology, evaluates the patient and determines that a peripheral nerve block is indicated for pain management. Using CPT code 64450, the provider injects an anesthetic and/or steroid near the affected peripheral nerve (such as the trigeminal or occipital nerve) to relieve pain. The procedure is performed in an office setting, and documentation includes the nerve targeted, medication used, and patient response.
Coding Specifications
-
Modifiers:
-
Modifier
50(Bilateral Procedure): Used when the injection is performed on both sides of the body, such as bilateral occipital nerve blocks. -
Modifier
59(Distinct Procedural Service): Used when the injection is performed as a separate and distinct service from other procedures on the same day.
-
-
Provider Taxonomies:
Taxonomy Code Specialty Name 207L00000XAnesthesiology 208VP0000XPain Medicine Physician 207R00000XInternal Medicine Physician
These taxonomies represent providers who commonly perform peripheral nerve blocks for pain management or diagnostic purposes.
Related Diagnoses
-
B02.22- Postherpetic trigeminal neuralgia- Indicates nerve pain following herpes zoster affecting the trigeminal nerve. Relevant for nerve block to manage neuralgia.
-
B02.23- Postherpetic polyneuropathy- Refers to multiple nerve involvement after herpes zoster. Nerve block may be used for pain relief.
-
B02.9- Zoster without complications- General herpes zoster diagnosis. Nerve block may be indicated for pain management.
-
C00.0- Malignant neoplasm of external upper lip- Cancer affecting the upper lip. Nerve block may be used for pain control in affected areas.
-
C00.1- Malignant neoplasm of external lower lip- Cancer affecting the lower lip. Nerve block may be used for pain management.
-
C00.3- Malignant neoplasm of upper lip, inner aspect- Cancer of the inner upper lip. Nerve block may help with pain control.
-
C00.4- Malignant neoplasm of lower lip, inner aspect- Cancer of the inner lower lip. Nerve block may be used for pain relief.
-
C00.6- Malignant neoplasm of commissure of lip, unspecified- Cancer at the lip commissure. Nerve block may assist with pain management.
-
C00.8- Malignant neoplasm of overlapping sites of lip- Cancer involving multiple lip sites. Nerve block may be used for pain control.
-
C00.9- Malignant neoplasm of lip, unspecified- Unspecified lip cancer. Nerve block may be indicated for pain management.
Related CPT Codes
-
20550- Injection(s); single tendon sheath, or ligament, aponeurosis- Used for injections into tendon sheaths or ligaments, often for musculoskeletal pain. Not typically performed with
64450, but may be considered in differential diagnosis or treatment of pain.
- Used for injections into tendon sheaths or ligaments, often for musculoskeletal pain. Not typically performed with
-
20610- Arthrocentesis, aspiration and/or injection into a major joint or bursa- Used for joint or bursa injections, unrelated to peripheral nerve blocks. May be performed in patients with joint pain as an alternative to nerve block.
-
64405- Injection, anesthetic agent; greater occipital nerve- Specifically for greater occipital nerve blocks. May be used instead of
64450when targeting this nerve.
- Specifically for greater occipital nerve blocks. May be used instead of
-
64455- Injection(s), anesthetic agent and/or steroid; plantar common digital nerve(s) (e.g., Morton's neuroma)- Used for injections in the foot for Morton's neuroma. Not typically performed with
64450, but both codes involve peripheral nerve injections.
- Used for injections in the foot for Morton's neuroma. Not typically performed with
Codes 64405 and 64455 are alternatives to 64450 when targeting specific nerves. 20550 and 20610 are used for other injection sites and are not commonly billed together with 64450.
National Reimbursement Benchmarks
For CPT code 64450, the national mean rate for Medicare is $83.83, while the average commercial benchmark (BUCA) is higher at $94.54. Among individual commercial payers, UnitedHealth Group has the highest mean rate at $122.90, and Cigna also stands out with a mean rate of $113.10. Blue Cross Blue Shield and Aetna are closer to the BUCA average, with mean rates of $90.23 and $87.13, respectively.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Medicare shows the tightest range at $9.00, indicating relatively consistent rates nationally. In contrast, UnitedHealth Group has the widest range at $62.92, followed by Cigna at $59.20, reflecting greater variability in commercial reimbursement. The table and chart below present the full breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.